TwinBeech Capital’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
TwinBeech Capital's AMED Position: Q4 2021 in Review
TwinBeech Capital sold out of Amedisys (AMED) in Q4 2021, closing a stake of 20,033 shares — an estimated $2.99M sold.
TwinBeech Capital first reported a position in AMED in Q3 2020 and held it in 3 quarters. The position peaked at $2.99M in Q3 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.
- TwinBeech Capital reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
- TwinBeech Capital sold 20,033 Amedisys shares in Q4 2021, an estimated $2.99M.
- TwinBeech Capital first reported a position in Amedisys in Q3 2020 and held it in 3 quarters.
- TwinBeech Capital's Amedisys position peaked at $2.99M in Q3 2021.
- 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.
Based on TwinBeech Capital's 13F filing for Q4 2021, filed 14 Feb 2022.